Skip to main content
Top
Published in: Reviews in Endocrine and Metabolic Disorders 2/2010

01-06-2010

The diagnosis of Cushing’s syndrome

Authors: Ty B. Carroll, James W. Findling

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 2/2010

Login to get access

Abstract

Spontaneous Cushing’s syndrome is well known but unusual clinical disorder. Many of the clinical features (central weight gain, glucose intolerance, hypertension, muscle weakness) are seen in other common conditions. Recognition of patients with multiple features, features unusual for their age (i.e. early onset osteoporosis or hypertension), patients with features more specific to Cushing’s syndrome (i.e. easy bruising, facial plethora, and violaceous striae), and patients with incidental adrenal mass or polycystic ovary syndrome should prompt an evaluation for cortisol excess. Late-night salivary cortisol, 1 mg overnight dexamethasone suppression testing, or 24 h urine free cortisol determination have excellent diagnostic characteristics and should be obtain in patients with suspected Cushing’ syndrome. If this initial testing is abnormal, further evaluation should be directed by an endocrinologist experienced in the diagnosis and differential diagnosis of Cushing’ syndrome.
Literature
1.
go back to reference Swearingen B, Biller BM, Barker 2nd FG, et al. Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med. 1999;130:821–4.PubMed Swearingen B, Biller BM, Barker 2nd FG, et al. Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med. 1999;130:821–4.PubMed
2.
go back to reference Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93:1526–40.CrossRefPubMed Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93:1526–40.CrossRefPubMed
3.
go back to reference Etxabe J, Vazquez JA. Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin Endocrinol (Oxf). 1994;40:479–84.CrossRef Etxabe J, Vazquez JA. Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin Endocrinol (Oxf). 1994;40:479–84.CrossRef
4.
go back to reference Lindholm J, Juul S, Jorgensen JO, et al. Incidence and late prognosis of cushing’s syndrome: a population-based study. J Clin Endocrinol Metab. 2001;86:117–23.CrossRefPubMed Lindholm J, Juul S, Jorgensen JO, et al. Incidence and late prognosis of cushing’s syndrome: a population-based study. J Clin Endocrinol Metab. 2001;86:117–23.CrossRefPubMed
5.
go back to reference Anderson Jr GH, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens. 1994;12:609–15.CrossRefPubMed Anderson Jr GH, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens. 1994;12:609–15.CrossRefPubMed
6.
go back to reference Omura M, Saito J, Yamaguchi K, et al. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004;27:193–202.CrossRefPubMed Omura M, Saito J, Yamaguchi K, et al. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004;27:193–202.CrossRefPubMed
7.
go back to reference Reincke M, Nieke J, Krestin GP, et al. Preclinical Cushing’s syndrome in adrenal “incidentalomas”: comparison with adrenal Cushing’s syndrome. J Clin Endocrinol Metab. 1992;75:826–32.CrossRefPubMed Reincke M, Nieke J, Krestin GP, et al. Preclinical Cushing’s syndrome in adrenal “incidentalomas”: comparison with adrenal Cushing’s syndrome. J Clin Endocrinol Metab. 1992;75:826–32.CrossRefPubMed
8.
go back to reference Terzolo M, Pia A, Ali A, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab. 2002;87:998–1003.CrossRefPubMed Terzolo M, Pia A, Ali A, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab. 2002;87:998–1003.CrossRefPubMed
9.
go back to reference Catargi B, Rigalleau V, Poussin A, et al. Occult Cushing’s syndrome in type-2 diabetes. J Clin Endocrinol Metab. 2003;88:5808–13.CrossRefPubMed Catargi B, Rigalleau V, Poussin A, et al. Occult Cushing’s syndrome in type-2 diabetes. J Clin Endocrinol Metab. 2003;88:5808–13.CrossRefPubMed
10.
go back to reference Leibowitz G, Tsur A, Chayen SD, et al. Pre-clinical Cushing’s syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf). 1996;44:717–22.CrossRef Leibowitz G, Tsur A, Chayen SD, et al. Pre-clinical Cushing’s syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf). 1996;44:717–22.CrossRef
11.
go back to reference Chiodini I, Mascia ML, Muscarella S, et al. Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann Intern Med. 2007;147:541–8.PubMed Chiodini I, Mascia ML, Muscarella S, et al. Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann Intern Med. 2007;147:541–8.PubMed
12.
go back to reference Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet. 2006;367:1605–17.CrossRefPubMed Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet. 2006;367:1605–17.CrossRefPubMed
13.
go back to reference Kelly W. Exophthalmos in Cushing’s syndrome. Clin Endocrinol (Oxf). 1996;45:167–70.CrossRef Kelly W. Exophthalmos in Cushing’s syndrome. Clin Endocrinol (Oxf). 1996;45:167–70.CrossRef
14.
go back to reference Bouzas EA, Mastorakos G, Chrousos GP, Kaiser-Kupfer MI. Lisch nodules in Cushing’s disease. Arch Ophthalmol. 1993;111:439–40.PubMed Bouzas EA, Mastorakos G, Chrousos GP, Kaiser-Kupfer MI. Lisch nodules in Cushing’s disease. Arch Ophthalmol. 1993;111:439–40.PubMed
15.
go back to reference Bouzas EA, Scott MH, Mastorakos G, et al. Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol. 1993;111:1229–33.PubMed Bouzas EA, Scott MH, Mastorakos G, et al. Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol. 1993;111:1229–33.PubMed
16.
go back to reference Bourdeau I, Bard C, Forget H, et al. Cognitive function and cerebral assessment in patients who have Cushing's syndrome. Endocrinol Metab Clin North Am. 2005;34:357. 69, ix.CrossRefPubMed Bourdeau I, Bard C, Forget H, et al. Cognitive function and cerebral assessment in patients who have Cushing's syndrome. Endocrinol Metab Clin North Am. 2005;34:357. 69, ix.CrossRefPubMed
17.
go back to reference Raff H, Findling JW. A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med. 2003;138:980–91.PubMed Raff H, Findling JW. A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med. 2003;138:980–91.PubMed
18.
go back to reference RP DOE, JA VENNES, EB FLINK. Diurnal variation of 17-hydroxycorticosteroids, sodium, potassium, magnesium and creatinine in normal subjects and in cases of treated adrenal insufficiency and Cushing’s syndrome. J Clin Endocrinol Metab. 1960;20:253–65.CrossRef RP DOE, JA VENNES, EB FLINK. Diurnal variation of 17-hydroxycorticosteroids, sodium, potassium, magnesium and creatinine in normal subjects and in cases of treated adrenal insufficiency and Cushing’s syndrome. J Clin Endocrinol Metab. 1960;20:253–65.CrossRef
19.
go back to reference Glass AR, Zavadil 3rd AP, Halberg F, et al. Circadian rhythm of serum cortisol in Cushing’s disease. J Clin Endocrinol Metab. 1984;59:161–5.CrossRefPubMed Glass AR, Zavadil 3rd AP, Halberg F, et al. Circadian rhythm of serum cortisol in Cushing’s disease. J Clin Endocrinol Metab. 1984;59:161–5.CrossRefPubMed
20.
go back to reference Refetoff S, Van Cauter E, Fang VS, et al. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing’s syndrome. J Clin Endocrinol Metab. 1985;60:527–35.CrossRefPubMed Refetoff S, Van Cauter E, Fang VS, et al. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing’s syndrome. J Clin Endocrinol Metab. 1985;60:527–35.CrossRefPubMed
21.
go back to reference Bolufer P, Gandia A, Rodriguez A, Antonio P. Salivary corticosteroids in the study of adrenal function. Clin Chim Acta. 1989;183:217–25.CrossRefPubMed Bolufer P, Gandia A, Rodriguez A, Antonio P. Salivary corticosteroids in the study of adrenal function. Clin Chim Acta. 1989;183:217–25.CrossRefPubMed
22.
go back to reference Kahn JP, Rubinow DR, Davis CL, et al. Salivary cortisol: a practical method for evaluation of adrenal function. Biol Psychiatry. 1988;23:335–49.CrossRefPubMed Kahn JP, Rubinow DR, Davis CL, et al. Salivary cortisol: a practical method for evaluation of adrenal function. Biol Psychiatry. 1988;23:335–49.CrossRefPubMed
23.
go back to reference Reid JD, Intrieri RC, Susman EJ, Beard JL. The relationship of serum and salivary cortisol in a sample of healthy elderly. J Gerontol. 1992;47:P176–9.PubMed Reid JD, Intrieri RC, Susman EJ, Beard JL. The relationship of serum and salivary cortisol in a sample of healthy elderly. J Gerontol. 1992;47:P176–9.PubMed
24.
go back to reference Read GF, Walker RF, Wilson DW, Griffiths K. Steroid analysis in saliva for the assessment of endocrine function. Ann N Y Acad Sci. 1990;595:260–74.CrossRefPubMed Read GF, Walker RF, Wilson DW, Griffiths K. Steroid analysis in saliva for the assessment of endocrine function. Ann N Y Acad Sci. 1990;595:260–74.CrossRefPubMed
25.
go back to reference Carroll T, Raff H, Findling JW. Late-night salivary cortisol measurement in the diagnosis of Cushing’s syndrome. Nat Clin Pract Endocrinol Metab. 2008;4:344–50.CrossRefPubMed Carroll T, Raff H, Findling JW. Late-night salivary cortisol measurement in the diagnosis of Cushing’s syndrome. Nat Clin Pract Endocrinol Metab. 2008;4:344–50.CrossRefPubMed
26.
go back to reference Elamin MB, Murad MH, Mullan R, et al. Accuracy of diagnostic tests for Cushing’s syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab. 2008;93:1553–62.CrossRefPubMed Elamin MB, Murad MH, Mullan R, et al. Accuracy of diagnostic tests for Cushing’s syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab. 2008;93:1553–62.CrossRefPubMed
27.
go back to reference Keller J, Flores B, Gomez RG, et al. Cortisol circadian rhythm alterations in psychotic major depression. Biol Psychiatry. 2006;60:275–81.CrossRefPubMed Keller J, Flores B, Gomez RG, et al. Cortisol circadian rhythm alterations in psychotic major depression. Biol Psychiatry. 2006;60:275–81.CrossRefPubMed
28.
go back to reference Carroll BJ, Cassidy F, Naftolowitz D, et al. Pathophysiology of hypercortisolism in depression. Acta Psychiatr Scand Suppl. 2007;115:90–103.CrossRef Carroll BJ, Cassidy F, Naftolowitz D, et al. Pathophysiology of hypercortisolism in depression. Acta Psychiatr Scand Suppl. 2007;115:90–103.CrossRef
29.
go back to reference Jones NM, Holzman CB, Zanella AJ, et al. Assessing mid-trimester salivary cortisol levels across three consecutive days in pregnant women using an at-home collection protocol. Paediatr Perinat Epidemiol. 2006;20:425–37.CrossRefPubMed Jones NM, Holzman CB, Zanella AJ, et al. Assessing mid-trimester salivary cortisol levels across three consecutive days in pregnant women using an at-home collection protocol. Paediatr Perinat Epidemiol. 2006;20:425–37.CrossRefPubMed
30.
go back to reference Carr BR, Parker Jr CR, Madden JD, et al. Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy. Am J Obstet Gynecol. 1981;139:416–22.PubMed Carr BR, Parker Jr CR, Madden JD, et al. Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy. Am J Obstet Gynecol. 1981;139:416–22.PubMed
31.
go back to reference Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev. 1998;19:647–72.CrossRefPubMed Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev. 1998;19:647–72.CrossRefPubMed
32.
go back to reference Gorges R, Knappe G, Gerl H, et al. Diagnosis of Cushing’s syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group. J Endocrinol Invest. 1999;22:241–9.PubMed Gorges R, Knappe G, Gerl H, et al. Diagnosis of Cushing’s syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group. J Endocrinol Invest. 1999;22:241–9.PubMed
33.
go back to reference Findling JW, Raff H, Aron DC. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing’s syndrome. J Clin Endocrinol Metab. 2004;89:1222–6.CrossRefPubMed Findling JW, Raff H, Aron DC. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing’s syndrome. J Clin Endocrinol Metab. 2004;89:1222–6.CrossRefPubMed
34.
go back to reference Wood PJ, Barth JH, Freedman DB, et al. Evidence for the low dose dexamethasone suppression test to screen for Cushing’s syndrome–recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem. 1997;34(Pt 3):222–9.PubMed Wood PJ, Barth JH, Freedman DB, et al. Evidence for the low dose dexamethasone suppression test to screen for Cushing’s syndrome–recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem. 1997;34(Pt 3):222–9.PubMed
35.
go back to reference Kyriazopoulou V, Vagenakis AG. Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy. J Clin Endocrinol Metab. 1992;75:315–7.CrossRefPubMed Kyriazopoulou V, Vagenakis AG. Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy. J Clin Endocrinol Metab. 1992;75:315–7.CrossRefPubMed
36.
go back to reference Castro M, Elias PC, Quidute AR, et al. Out-patient screening for Cushing’s syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests. J Clin Endocrinol Metab. 1999;84:878–82.CrossRefPubMed Castro M, Elias PC, Quidute AR, et al. Out-patient screening for Cushing’s syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests. J Clin Endocrinol Metab. 1999;84:878–82.CrossRefPubMed
37.
go back to reference Yaneva M, Mosnier-Pudar H, Dugue MA, et al. Midnight salivary cortisol for the initial diagnosis of Cushing’s syndrome of various causes. J Clin Endocrinol Metab. 2004;89:3345–51.CrossRefPubMed Yaneva M, Mosnier-Pudar H, Dugue MA, et al. Midnight salivary cortisol for the initial diagnosis of Cushing’s syndrome of various causes. J Clin Endocrinol Metab. 2004;89:3345–51.CrossRefPubMed
38.
go back to reference Papanicolaou DA, Yanovski JA, Cutler Jr GB, et al. A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing states. J Clin Endocrinol Metab. 1998;83:1163–7.CrossRefPubMed Papanicolaou DA, Yanovski JA, Cutler Jr GB, et al. A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing states. J Clin Endocrinol Metab. 1998;83:1163–7.CrossRefPubMed
39.
go back to reference Papanicolaou DA, Mullen N, Kyrou I, Nieman LK. Nighttime salivary cortisol: a useful test for the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab. 2002;87:4515–21.CrossRefPubMed Papanicolaou DA, Mullen N, Kyrou I, Nieman LK. Nighttime salivary cortisol: a useful test for the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab. 2002;87:4515–21.CrossRefPubMed
40.
go back to reference Meikle AW, Findling J, Kushnir MM, et al. Pseudo-Cushing syndrome caused by fenofibrate interference with urinary cortisol assayed by high-performance liquid chromatography. J Clin Endocrinol Metab. 2003;88:3521–4.CrossRefPubMed Meikle AW, Findling J, Kushnir MM, et al. Pseudo-Cushing syndrome caused by fenofibrate interference with urinary cortisol assayed by high-performance liquid chromatography. J Clin Endocrinol Metab. 2003;88:3521–4.CrossRefPubMed
41.
go back to reference Findling JW, Pinkstaff SM, Shaker JL, et al. Pseudohypercortisoluria: spurious elevation of urinary cortisol due to carbamazepine. Endocrinologist. 1998;8:51.CrossRef Findling JW, Pinkstaff SM, Shaker JL, et al. Pseudohypercortisoluria: spurious elevation of urinary cortisol due to carbamazepine. Endocrinologist. 1998;8:51.CrossRef
42.
go back to reference Masserini B, Morelli V, Bergamaschi S, et al. The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. Eur J Endocrinol. 2009;160:87–92.CrossRefPubMed Masserini B, Morelli V, Bergamaschi S, et al. The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. Eur J Endocrinol. 2009;160:87–92.CrossRefPubMed
43.
go back to reference Nunes ML, Vattaut S, Corcuff JB, et al. Late-night salivary cortisol for diagnosis of overt and subclinical Cushing’s syndrome in hospitalized and ambulatory patients. J Clin Endocrinol Metab. 2009;94:456–62.CrossRefPubMed Nunes ML, Vattaut S, Corcuff JB, et al. Late-night salivary cortisol for diagnosis of overt and subclinical Cushing’s syndrome in hospitalized and ambulatory patients. J Clin Endocrinol Metab. 2009;94:456–62.CrossRefPubMed
44.
go back to reference Reimondo G, Allasino B, Bovio S, et al. Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing’s syndrome. Eur J Endocrinol. 2005;153:803–9.CrossRefPubMed Reimondo G, Allasino B, Bovio S, et al. Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing’s syndrome. Eur J Endocrinol. 2005;153:803–9.CrossRefPubMed
45.
go back to reference Patil CG, Prevedello DM, Lad SP, et al. Late recurrences of Cushing’s disease after initial successful transsphenoidal surgery. J Clin Endocrinol Metab. 2008;93:358–62.CrossRefPubMed Patil CG, Prevedello DM, Lad SP, et al. Late recurrences of Cushing’s disease after initial successful transsphenoidal surgery. J Clin Endocrinol Metab. 2008;93:358–62.CrossRefPubMed
46.
go back to reference Toms GC, McCarthy MI, Niven MJ, et al. Predicting relapse after transsphenoidal surgery for Cushing’s disease. J Clin Endocrinol Metab. 1993;76:291–4.CrossRefPubMed Toms GC, McCarthy MI, Niven MJ, et al. Predicting relapse after transsphenoidal surgery for Cushing’s disease. J Clin Endocrinol Metab. 1993;76:291–4.CrossRefPubMed
47.
go back to reference Trainer PJ, Lawrie HS, Verhelst J, et al. Transsphenoidal resection in Cushing’s disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf). 1993;38:73–8.CrossRef Trainer PJ, Lawrie HS, Verhelst J, et al. Transsphenoidal resection in Cushing’s disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf). 1993;38:73–8.CrossRef
48.
go back to reference Losa M, Bianchi R, Barzaghi R, et al. Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing’s disease. J Clin Endocrinol Metab. 2009;94:3322–8.CrossRefPubMed Losa M, Bianchi R, Barzaghi R, et al. Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing’s disease. J Clin Endocrinol Metab. 2009;94:3322–8.CrossRefPubMed
49.
go back to reference Romanholi DJ, Machado MC, Pereira CC, et al. Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing’s disease. Clin Endocrinol (Oxf). 2008;69:117–22.CrossRef Romanholi DJ, Machado MC, Pereira CC, et al. Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing’s disease. Clin Endocrinol (Oxf). 2008;69:117–22.CrossRef
50.
go back to reference Carrasco CA, Coste J, Guignat L et al (2008) Midnight Salivary Cortisol Determination for Assessing the Outcome of Transsphenoidal Surgery in Cushing’s Disease. J Clin Endocrinol Metab Carrasco CA, Coste J, Guignat L et al (2008) Midnight Salivary Cortisol Determination for Assessing the Outcome of Transsphenoidal Surgery in Cushing’s Disease. J Clin Endocrinol Metab
Metadata
Title
The diagnosis of Cushing’s syndrome
Authors
Ty B. Carroll
James W. Findling
Publication date
01-06-2010
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 2/2010
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-010-9143-3

Other articles of this Issue 2/2010

Reviews in Endocrine and Metabolic Disorders 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.